ST Pharm Co.,Ltd. (237690.KQ) KOE
Currency In KRW
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.45T |
| Enterprise Value | 2.5T |
| P/E Ratio | 24.35 |
| PEG Ratio | 0.21 |
| Price/Sales Ratio | 4.85 |
| Price/Book Ratio | 2.97 |
| Enterprise/Revenue | 4.91 |
| Enterprise/EBITDA | 18.18 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.2 |
| Operating Margin | 0.18 |
AD
Management Effectiveness
| Return On Assets | 0.09 |
| Return On Equity | 0.13 |
Income Statement
| Revenue | 331.55B |
| Revenue/Share | 18,591.27 |
| Gross Profit | 129.32B |
| EBITDA | 84.4B |
| Net Income | 54.99B |
| Diluted EPS | 2,688.35 |
Balance Sheet
| Total Cash | 183.41B |
| Total Cash/Share | 8,826.3 |
| Total Debt | 74.81B |
| Total Debt/Equity | 0.12 |
| Current Ratio | 2.28 |
| Book Value Per Share | 30,272.9 |
Price History
| 52-Week Change | -1.53 |
| 52-Week High | 172,100 |
| 52-Week Low | 84,100 |
| Moving Average 50 Days | 108,310 |
| Moving Average 200 Days | 129,845.5 |
Statistics
| Average Volume | 162,596 |
| Shares Outstanding | 20.84M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 500 |
| Trailing Annual Dividend Yield | 0.56 |
| Payout Ratio | 0.14 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
